Travel Expense Rebates And Incentives Result In $40 Million FCA Settlement
Client Alert | less than 1 min read | 07.29.05
PricewaterhouseCoopers has agreed to pay $41.9 million to settle a qui tam civil False Claims Act lawsuit brought by a former partner alleging that the accounting firm had knowingly overbilled various government agencies for travel in conjunction with auditing and consulting work by failing to give the government credit for commissions, rebates, and incentives that travel companies and credit card issuers extended to the firm. The former partner turned whistleblower, who alleged that the accounting firm's management ignored internal complaints about the practice, reportedly is expected to receive between 15 and 25 percent of the government's $41.9 million recovery, plus $1.6 million in legal fees and costs.
Insights
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
On April 6, 2026, the Centers for Medicare & Medicaid Services (CMS) published its final rule governing the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs for Contract Year (CY) 2027. The final rule is effective June 1, 2026, with most provisions applicable to coverage beginning January 1, 2027, and marketing and communications changes taking effect October 1, 2026. Beyond payment, the rule pursues a broad deregulatory agenda aligned with Executive Order 14192, reversing marketing and enrollment safeguards introduced in 2023 and easing documentation and reporting obligations, while introducing new program integrity requirements.
Client Alert | 1 min read | 04.17.26
Client Alert | 3 min read | 04.17.26
Client Alert | 2 min read | 04.16.26
